Schizophrenia Genetics Linked to Disruption in How Brain Processes Sound

Pin It

Recent studies have identified many genes that may put people with schizophrenia at risk for the disease. But, what links genetic differences to changes in altered brain activity in schizophrenia is not clear. Now, three labs at the Perelman School of Medicine at the University of Pennsylvania have come together using electrophysiological, anatomical, and immunohistochemical approaches — along with a unique high-speed imaging technique — to understand how schizophrenia works at the cellular level, especially in identifying how changes in the interaction between different types of nerve cells leads to symptoms of the disease.

The findings are reported this week in the Proceedings of the National Academy of Sciences.

“Our work provides a model linking genetic risk factors for schizophrenia to a functional disruption in how the brain responds to sound, by identifying reduced activity in special nerve cells that are designed to make other cells in the brain work together at a very fast pace” explains lead author Gregory Carlson, PhD, assistant professor of Neuroscience in Psychiatry. “We know that in schizophrenia this ability is reduced, and now, knowing more about why this happens may help explain how loss of a protein called dysbindin leads to some symptoms of schizophrenia.”

Previous genetic studies had found that some forms of the gene for dysbindin were found in people with schizophrenia. Most importantly, a prior finding at Penn showed that the dysbindin protein is reduced in a majority of schizophrenia patients, suggesting it is involved in a common cause of the disease….

The above story is reprinted from materials provided by University of Pennsylvania School of Medicine.

ScienceDaily

http://www.sciencedaily.com/releases/2011/10/111013153945.htm

Comments

  1. Depression Supplements: Several prescription medications are effective, however they don’t always result in the full remission of symptoms and they are often poorly tolerated, especially in the elderly. There is a lot of cross over between anxiety and depression, with many people suffering from both concurrently. Similarly the medications and supplements used in depression also modulates the monoamines, namely serotonin, norepinephrine, and dopamine. A few I have found helpful include Chromium Picolinate, Fish oil, 5-HTP, L-Methlyfolate St. John’s Wort, and SAMe.

Speak Your Mind

*